Literature DB >> 11948754

Pathophysiology of nonparkinsonian tremors.

Günther Deuschl1, Hagai Bergman.   

Abstract

Patients with nonparkinsonian tremors are the second largest group treated with functional neurosurgery. We summarize the present pathophysiological knowledge of these conditions. Essential tremor (ET) may be due to oscillations within the olivocerebellar circuit. There is experimental evidence from animal models for such a mechanism, and clinical data indicate an abnormal function of the cerebellum in ET. Cerebellar tremor may be closely related to the tremor seen in advanced ET. The malfunction of the cerebellum causes a pathological feed-forward control. Additionally an oscillator within the cerebellum or its input/output pathways may cause cerebellar tremor. Almost nothing is known about the pathophysiology of dystonic tremor. Holmes tremor is based on a nigral and a cerebellar malfunction and presents clinically as the combination of tremor in Parkinson's disease and cerebellar tremor. Neuropathic tremor can be extremely disabling and is thought to be due to an abnormal interaction of the disturbances within the periphery and abnormal cerebellar feedback. Unlike the case of Parkinson's disease, functional neurosurgery of nonparkinsonian tremors is not yet based on a solid pathophysiological background. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 11948754     DOI: 10.1002/mds.10141

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  40 in total

1.  Holmes tremor after brainstem hemorrhage, treated with levodopa.

Authors:  Jae Hyun Woo; Bo Young Hong; Joon Sung Kim; Seok Ho Moon; Soo Yeon Kim; Hye Young Han; Dong Yoon Park; Seong Hoon Lim
Journal:  Ann Rehabil Med       Date:  2013-08-26

2.  Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors:  Carlo Canepa
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 3.  Milestones in clinical neurophysiology.

Authors:  Mark Hallett; John Rothwell
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

4.  Botulinum toxin type A for Holmes tremor secondary to thalamic hemorrhage.

Authors:  Pamela Latino; Francesco E Pontieri; Francesco Orzi; Morena Giovannelli
Journal:  Neurol Sci       Date:  2015-06-29       Impact factor: 3.307

5.  SCA 6 with Writer's Cramp: The Phenotype Expanded.

Authors:  Diana Angelika Olszewska; Richard Walsh; Tim Lynch
Journal:  Mov Disord Clin Pract       Date:  2015-08-26

6.  Reversible Holmes' tremor due to spontaneous intracranial hypotension.

Authors:  Rajesh Shankar Iyer; Pandurang Wattamwar; Bejoy Thomas
Journal:  BMJ Case Rep       Date:  2017-07-27

Review 7.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

8.  Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Authors:  Luis Querol; Gisela Nogales-Gadea; Ricardo Rojas-Garcia; Jordi Diaz-Manera; Julio Pardo; Angel Ortega-Moreno; Maria Jose Sedano; Eduard Gallardo; Jose Berciano; Rafael Blesa; Josep Dalmau; Isabel Illa
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

Review 9.  An update on essential tremor.

Authors:  Rodger J Elble; Günther Deuschl
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

10.  Relationship between essential tremor and cerebellar dysfunction according to age.

Authors:  Eui-Seong Lim; Man-Wook Seo; Seong-Ryong Woo; Suk-Young Jeong; Seul-Ki Jeong
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.